EXAS Share Price

Open 34.60 Change Price %
High 35.60 1 Day 0.80 2.30
Low 34.10 1 Week 3.24 10.04
Close 35.51 1 Month 2.55 7.74
Volume 2163158 1 Year 23.97 207.71
52 Week High 38.92
52 Week Low 10.54
EXAS Important Levels
Resistance 2 36.90
Resistance 1 36.33
Pivot 35.07
Support 1 34.69
Support 2 34.12
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
DCTH 0.16 -33.33%
FTR 1.22 8.93%
FTR 1.22 8.93%
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
More..
NASDAQ USA Top Gainers Stocks
OPXAW 0.12 200.00%
AVEO 1.25 71.23%
LOCM 0.09 50.00%
MYRX 0.09 50.00%
SNCR 16.24 33.33%
QUIK 1.60 31.15%
WRES 0.09 28.57%
IIN 8.35 27.48%
IIN 8.35 27.48%
IIN 8.35 27.48%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
TOPS 0.80 -66.67%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

EXACT Sciences Corporation (NASDAQ: EXAS)

EXAS Technical Analysis 5
As on 23rd Jun 2017 EXAS Share Price closed @ 35.51 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 21.31 & Strong Buy for SHORT-TERM with Stoploss of 30.90 we also expect STOCK to react on Following IMPORTANT LEVELS.
EXAS Target for June
1st Target up-side 40.39
2nd Target up-side 43.14
3rd Target up-side 45.88
1st Target down-side 32.55
2nd Target down-side 29.8
3rd Target down-side 27.06
EXAS Other Details
Segment EQ
Market Capital 594952448.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.exactsciences.com
EXAS Address
EXAS
441 Charmany Drive
Madison, WI 53719
United States
Phone: 608-284-5700
Fax: 608-284-5701
EXAS Latest News
Interactive Technical Analysis Chart EXACT Sciences Corporation ( EXAS NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on EXACT Sciences Corporation
EXAS Business Profile
Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. The Company�s Cologuard test is a non-invasive, stool-based DNA (sDNA) screening test designed to detect deoxyribonucleic acid (DNA) markers, which in published studies have been shown to be associated with colorectal cancer. In addition to DNA markers, its test includes a protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test (FIT). The Company�s Cologuard test is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. The target sensitivity rate of its Cologuard test for cancer is equal to or greater than 85% at a specificity of 90%.